MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Putative treatment of Parkinson’s Disease using extract of Bacopa monnieri

S. Sinha, P. Kumar (Allahabad, India)

Meeting: 2018 International Congress

Abstract Number: 338

Keywords: Parkinsonism, Rapid-onset dystonia-parkinsonism(RDP)

Session Information

Date: Saturday, October 6, 2018

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: Bacopa monnieri is largely treasured as a revitalizing herb used by Ayurvedic medical practitioners for almost 3000 years. The herb has been mentioned in several Ayurvedic treatises including Charaka Samhita and Sushruta Samhita in the 3rd century AD. Bacopa monnieri may improve circulation to the brain and even protect brain cell hence could be used as a potent agent against development of PD.

Background: Parkinson’s Disease (PD), is the contemporary name for a degenerative brain disease that has been recorded by humans. In ancient India, the practitioners of the medical system Ayurveda called it Kampavada. Bacopa monnieri is used in India since ancient times is also a day to day use herb.

Methods: A total of 50 adult male Wistar rats (NGBU, Laboratory Animal Center), weighting 200 g, were used. All model rats received 6-OHDA injection (6-OHDA injection: 6-OHDA, vitamin C powder, 0.3% 6-OHDA injection according to the ratio of 2.5:1 with saline. The injection was used when preparation and stored sealed, low temperature, and dark) stereotactic brain injection. After 6-OHDA administration 1d, 7d and 14d, 10 rats per group were observed every time. When the symptoms of PD progressed, we applied Bacopa monnieri seed powder extract in water to rodent models of Parkinson’s.

Results: Bacopa monnieri extract exhibits interesting antioxidant properties, expressed by its capacity to scavenge superoxide anion and hydroxyl radical, and to reduce H2O2 induced cytotoxicity and DNA damage in human fibroblast cells. Results showed promise in conquering the disease and protecting the brain from damage by the antioxidant activity of the extract in the hippocampus, frontal cortex and striatum.

Conclusions: Bacopa monnieri helps in coping with combined hypoxic, hypothermic and immobilization stress that could lead to the onslaught of ‘free radicals’ during the progress of PD.

To cite this abstract in AMA style:

S. Sinha, P. Kumar. Putative treatment of Parkinson’s Disease using extract of Bacopa monnieri [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/putative-treatment-of-parkinsons-disease-using-extract-of-bacopa-monnieri/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/putative-treatment-of-parkinsons-disease-using-extract-of-bacopa-monnieri/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley